FGF23 and myeloid sarcoma: Looking at gender differences, in female MS patients, the same correlations were found as described above, except for the correlations of FGF23 with serum 25(OH)D and 24.25(OH)2D (r 0.12, p = 0.37 and r 0.10, p = 0.44, respectively).